Could a COVID pill ease the misery of long haulers?

NCT ID NCT05576662

Summary

This study tested whether taking Paxlovid for 15 days helps reduce severe Long COVID symptoms better than a placebo. It involved 168 adults who had been struggling with symptoms like fatigue, brain fog, and shortness of breath for over three months. Researchers compared symptom severity over 15 weeks to see if the antiviral medication provided relief.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for LONG COVID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Stanford University

    Stanford, California, 94305, United States

Conditions

Explore the condition pages connected to this study.